Literature DB >> 16236459

Is there a causal relationship between the receipt of blood transfusions and the development of chronic lung disease of prematurity?

Keith J Collard1.   

Abstract

The number and total volume of blood transfusions received by premature babies is, after gestational age and birth weight a good predictor of the likelihood of developing chronic lung disease of prematurity (CLD) and retinopathy of prematurity (ROP). Oxidative damage, inflammation and pulmonary infections are also strongly associated with the development of CLD. It is currently not clear whether there is a causal relationship between the receipt of blood transfusions and oxidative damage, infection, inflammation and CLD in these babies. Strong arguments may be made both for and against a causal relationship. The babies who receive blood transfusions are usually smaller than those who do not, and are ventilated, often with high oxygen levels, for a longer period of time. The longer the baby is on a ventilator the more likely it is to develop pulmonary infection and inflammation. All these factors will promote free radical production and oxidative damage irrespective of the receipt of blood transfusion. This would argue against a causal relationship. On the other hand, an argument may be presented which is based on iron promoted free radical generation, infection and fibrosis consequent to the breakdown of haeme released from transfused erythrocytes. Haeme is broken down by haeme oxygenase (HO) to iron, CO and bilirubin. Under normal circumstances the products of HO activity are beneficial to the organism, but when HO activity is excessive, the products are potentially damaging. Free iron, (in the Fe2+ form) if not sequestered with protein or urate, will generate highly toxic free radicals via the Fenton and Heber-Wiess reactions, predispose the tissue to infection and promote fibrosis. The iron chelating ability of the premature baby appears to be limited so that it would be difficult to deal with any increase in free iron production. Free iron will in turn induce HO activity leading to a potentially serious positive feedback process. The lung is particularly sensitive to iron induced HO activity. In addition, HO activity may be enhanced by other events occurring in the premature lung such as the production of proinflammatory cytokines and the reduced level of glutathione. Thus, the possibility of a causal relationship clearly exists and needs to be examined. This can be attempted by measuring the products of HO activity in relation to the receipt of blood transfusions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236459     DOI: 10.1016/j.mehy.2005.04.046

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  18 in total

1.  Enteral iron supplementation, red blood cell transfusion, and risk of bronchopulmonary dysplasia in very-low-birth-weight infants.

Authors:  Ravi Mangal Patel; Andrea Knezevic; Jing Yang; Neeta Shenvi; Michael Hinkes; John D Roback; Kirk A Easley; Cassandra D Josephson
Journal:  Transfusion       Date:  2019-02-23       Impact factor: 3.157

2.  The effect of maximum storage on iron status, oxidative stress and antioxidant protection in paediatric packed cell units.

Authors:  Keith Collard; Desley White; Adrian Copplestone
Journal:  Blood Transfus       Date:  2012-09-12       Impact factor: 3.443

Review 3.  Transfusion related morbidity in premature babies: Possible mechanisms and implications for practice.

Authors:  Keith James Collard
Journal:  World J Clin Pediatr       Date:  2014-08-08

4.  The influence of storage age on iron status, oxidative stress and antioxidant protection in paediatric packed cell units.

Authors:  Keith Collard; Desley White; Adrian Copplestone
Journal:  Blood Transfus       Date:  2013-11-29       Impact factor: 3.443

Review 5.  Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment.

Authors:  Jung S Hwang; Virender K Rehan
Journal:  Lung       Date:  2018-01-27       Impact factor: 2.584

6.  Effects of transfusions in extremely low birth weight infants: a retrospective study.

Authors:  Olga A Valieva; Thomas P Strandjord; Dennis E Mayock; Sandra E Juul
Journal:  J Pediatr       Date:  2009-09       Impact factor: 4.406

7.  Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates: Post Hoc Analysis of a Randomized Clinical Trial.

Authors:  Sandra E Juul; Phuong T Vu; Bryan A Comstock; Rajan Wadhawan; Dennis E Mayock; Sherry E Courtney; Tonya Robinson; Kaashif A Ahmad; Ellen Bendel-Stenzel; Mariana Baserga; Edmund F LaGamma; L Corbin Downey; Michael O'Shea; Raghavendra Rao; Nancy Fahim; Andrea Lampland; Ivan D Frantz; Janine Khan; Michael Weiss; Maureen M Gilmore; Robin Ohls; Nishant Srinivasan; Jorge E Perez; Victor McKay; Patrick J Heagerty
Journal:  JAMA Pediatr       Date:  2020-10-01       Impact factor: 16.193

8.  Feasibility of umbilical cord blood as a source of red blood cell transfusion in preterm infants.

Authors:  Elsa García González; Miguel Alsina Casanova; Dinara Samarkanova; Victoria Aldecoa-Bilbao; Marta Teresa-Palacio; Elisenda Farssac Busquets; Josep Figueras-Aloy; MªDolors Salvia-Roigés; Sergi Querol
Journal:  Blood Transfus       Date:  2020-12-18       Impact factor: 3.443

9.  Long-term outcome in relationship to neonatal transfusion volume in extremely premature infants: a comparative cohort study.

Authors:  Jeannette S von Lindern; Chantal M Khodabux; Karien E A Hack; Ingrid C van Haastert; Corine Koopman-Esseboom; Paul H T van Zwieten; Anneke Brand; Frans J Walther
Journal:  BMC Pediatr       Date:  2011-05-28       Impact factor: 2.125

10.  Risk factors of transfusion in anemia of very low birth weight infants.

Authors:  Ga Won Jeon; Jong Beom Sin
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.